Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and remoxipride

bromocriptine has been researched along with remoxipride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulton, AA; Juorio, AV; Paterson, IA; Zhu, MY1
Ahangari, G; Deezagi, A; Hejazi, SH; Pornour, M1
Ahangari, G; Bakhtou, H; Deezagi, A; Olfatbakhsh, A1

Other Studies

3 other study(ies) available for bromocriptine and remoxipride

ArticleYear
Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: Animals; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Drug Interactions; Ergolines; Flupenthixol; Male; Pimozide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Stereoisomerism

1993
New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line.
    Recent patents on anti-cancer drug discovery, 2015, Volume: 10, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromocriptine; Cell Survival; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Patents as Topic; Proliferating Cell Nuclear Antigen; Receptors, Dopamine D2; Remoxipride

2015
The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?
    Current drug discovery technologies, 2019, Volume: 16, Issue:2

    Topics: Adult; Apoptosis; Breast Neoplasms; Bromocriptine; Cabergoline; Cell Line, Tumor; Cell Proliferation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Leukocytes, Mononuclear; Middle Aged; Neoplasm Staging; Receptors, Dopamine; Receptors, Estrogen; Receptors, Progesterone; Remoxipride

2019